Details for Patent: 11,592,396
Which drugs does patent 11,592,396 protect, and when does it expire?
Patent 11,592,396 protects LUMISIGHT and is included in one NDA.
This patent has nine patent family members in four countries.
Summary for Patent: 11,592,396
| Title: | Methods and systems for spatially identifying abnormal cells |
| Abstract: | The present invention provides compositions and methods for imaging tumor resections. |
| Inventor(s): | W. David Lee, Moungi G. Bawendi, Jorge Ferrer |
| Assignee: | Lumicell Inc |
| Application Number: | US16/829,498 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 11,592,396
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lumicell | LUMISIGHT | pegulicianine acetate | POWDER;INTRAVENOUS | 214511-001 | Apr 17, 2024 | RX | Yes | Yes | 11,592,396 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,592,396
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011336660 | ⤷ Start Trial | |||
| Australia | 2016277654 | ⤷ Start Trial | |||
| Canada | 2824724 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
